Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
about
Overview of the biology of type I interferonsInterferon lambda: a new sword in cancer immunotherapyAlpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infectionMeta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinomaGenetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactionsComparison of antiviral activity of lambda-interferons against HIV replication in macrophagesA bacterial protein targets the BAHD1 chromatin complex to stimulate type III interferon responseConstitutive type I interferon modulates homeostatic balance through tonic signalingDisease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza virusesTranscriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complexInterferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neuronsIFN-λ3 inhibits HIV infection of macrophages through the JAK-STAT pathway.Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1).The airway epithelium: soldier in the fight against respiratory virusesInterferon-lambda3 (IFN-λ3) and its cognate receptor subunits in tree shrews (Tupaia belangeri): genomic sequence retrieval, molecular identification and expression analysisDendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response.Interferon-β produces synergistic combinatory anti-tumor effects with cisplatin or pemetrexed on mesothelioma cells.IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection.Interferon-lambda and therapy for chronic hepatitis C virus infectionAge-associated impaired plasmacytoid dendritic cell functions lead to decreased CD4 and CD8 T cell immunity.A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1IL28B is associated with outcomes of chronic HBV infectionAdenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effectsAssociation with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from MexicoInterferon lambda inhibits dengue virus replication in epithelial cells.Interferon-λ1 suppresses invasion and enhances autophagy in human osteosarcoma cell.HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer.Modeling Ribavirin-Induced Anemia in Patients with Chronic Hepatitis C VirusImmunomodulatory effects of interferons in malignancies.The Correlation Between Interferon Lambda 3 Gene Polymorphisms and Susceptibility to Hepatitis B Virus Infection.Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets.Interleukin-29 Enhances Synovial Inflammation and Cartilage Degradation in Osteoarthritis.Impaired secretion of interferons by dendritic cells from aged subjects to influenza : role of histone modifications.IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages.Progesterone activates multiple innate immune pathways in Chlamydia trachomatis-infected endocervical cells.Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection.Infections and the liver.IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection.
P2860
Q21195364-DA9A2936-6DB9-44A8-B1DB-E42FE73CD268Q21296797-06FF23F4-52BB-4518-A36F-C8AB32903210Q24611884-52C29377-BD89-4064-8165-D7E7503FF429Q26745585-5D3C26C7-D5D5-4B77-938B-B1293DB63CF7Q27014831-4A8AFBDA-23FE-403F-B81A-6CEF8D38389AQ27307732-B741A741-0FF4-49CD-B192-0AAF102BD541Q27666552-09DB078A-6AC6-4694-A167-90337F9AA5E5Q28260631-FCEAF72E-9862-49F6-9F6C-140AEC602FF5Q30363295-FB84BC25-CCB1-40D6-9EF4-57A69250D12AQ30407935-271780EC-AF39-41C6-95FF-AF8284C7F0FAQ30499869-A5DEA4FB-39C9-429D-89B7-6148F5DCAC73Q34256897-64C7B9CE-91F6-416A-9D95-695F878E652EQ34409699-932ABE34-5785-4136-8BB6-D5A47260982AQ34439839-533D682F-C30B-4381-949A-AF5CAAEE5CA6Q34491598-A0967D41-AC48-4527-B547-40CA9FA3C712Q34653087-B982AF9B-E16C-478F-B2FA-98FD9AD0AB7BQ34750577-93F8E8E6-FA4C-490C-9437-ACCB8991C410Q34974037-45A03B82-4396-4422-AB7A-91E9A1E5B52EQ35042843-87867C56-F6E4-403D-90CD-4931911570F9Q35186389-1AA71986-CFC4-4E77-94AA-9F43C13ED361Q35201154-6A12727F-1B3D-4476-B20A-F0D017063AD5Q35356926-C1991906-B4AA-4051-8626-CE27309C52B9Q35407009-0137EDEA-4646-425B-9CF0-221750886D48Q35421465-6EE9E9E4-2148-4E67-B07F-E3A41E720575Q35620657-637F56A2-C661-4A13-818C-5AADBA3C8B8AQ35887966-3F679E8E-F157-417C-B4DE-D8458B2F7B9BQ36096932-40D89082-5A38-473A-A3FB-8A5EF9119B83Q36317399-313E6CF7-8864-4F29-9533-5331AAFDC0F4Q36357062-D73D2392-65B1-4172-A410-88A87D0380FCQ36600070-FFD80B20-924F-45C7-86BE-E97EAD5E9DE9Q36825411-DB87D60F-7B61-4742-8D6C-E6811982D739Q36923172-898B7785-0D0F-4747-A3F1-9FD9C6DBF436Q36978822-92F22E2C-8F2F-4D81-8960-7518867528A2Q37084401-23CA7508-3FBD-429C-B178-5968A8D83D66Q37179927-208D0150-2971-434D-A275-043D0E04B958Q37681541-1F7150F8-5D68-4B24-B022-369ACE9F6ECDQ37845585-95435E50-B875-4583-80B5-2592916EFC74Q37879701-36216553-6F99-4D38-BF21-710608376C8BQ37898411-84C0BC41-0D98-4A0E-833F-F951A6C02694Q37921307-50B3EE22-C84B-446A-942F-50995FCC04F5
P2860
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@ast
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@en
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@nl
type
label
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@ast
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@en
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@nl
prefLabel
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@ast
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@en
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@nl
P2093
P2860
P3181
P356
P1476
Interferon-lambdas: the modulators of antivirus, antitumor, and immune responses
@en
P2093
Mingcai Li
Shao Bo Su
Xiaojin Liu
Yanchun Zhou
P2860
P3181
P356
10.1189/JLB.1208761
P407
P577
2009-07-01T00:00:00Z